Andrea Galli

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

SARS-CoV-2 Neutralization Breadth Is Shaped by Variant Exposure and Immune History.

SARS-CoV-2 Neutralization Breadth Is Shaped by Variant Exposure and Immune History.

Journal: Journal of medical virology
Published: November 20, 2025

Neutralisation resistance of SARS-CoV-2 spike-variants is primarily mediated by synergistic receptor binding domain substitutions.

Neutralisation resistance of SARS-CoV-2 spike-variants is primarily mediated by synergistic receptor binding domain substitutions.

Journal: Emerging microbes & infections
Published: October 11, 2024

Differential activity of nucleotide analogs against tick-borne encephalitis and yellow fever viruses in human cell lines.

Differential activity of nucleotide analogs against tick-borne encephalitis and yellow fever viruses in human cell lines.

Journal: Virology
Published: March 04, 2023

Mechanisms and Consequences of Genetic Variation in Hepatitis C Virus (HCV).

Mechanisms and Consequences of Genetic Variation in Hepatitis C Virus (HCV).

Journal: Current topics in microbiology and immunology
Published: January 02, 2023

Boldness and physiological variation in round goby populations along their Baltic Sea invasion front.

Boldness and physiological variation in round goby populations along their Baltic Sea invasion front.

Journal: Physiology & behavior
Published: December 05, 2022

Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.

Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.

Journal: Viruses
Published: December 01, 2021

High recombination rate of hepatitis C virus revealed by a green fluorescent protein reconstitution cell system.

High recombination rate of hepatitis C virus revealed by a green fluorescent protein reconstitution cell system.

Journal: Virus evolution
Published: September 27, 2021

Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro.

Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro.

Journal: Viruses
Published: August 31, 2021

Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro.

Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro.

Journal: Antimicrobial agents and chemotherapy
Published: June 07, 2021

Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication.

Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication.

Journal: Antimicrobial agents and chemotherapy
Published: April 27, 2021

Lipid Droplets Accumulation during Hepatitis C Virus Infection in Cell-Culture Varies among Genotype 1-3 Strains and Does Not Correlate with Virus Replication.

Lipid Droplets Accumulation during Hepatitis C Virus Infection in Cell-Culture Varies among Genotype 1-3 Strains and Does Not Correlate with Virus Replication.

Journal: Viruses
Published: January 08, 2021

Mutations Identified in the Hepatitis C Virus (HCV) Polymerase of Patients with Chronic HCV Treated with Ribavirin Cause Resistance and Affect Viral Replication Fidelity.

Mutations Identified in the Hepatitis C Virus (HCV) Polymerase of Patients with Chronic HCV Treated with Ribavirin Cause Resistance and Affect Viral Replication Fidelity.

Journal: Antimicrobial agents and chemotherapy
Published: July 05, 2020
Showing 1-12 of 21

Last Updated: 09/26/2026